Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
Arcutis Biotherapeutics (ARQT) Ownership Overview
9.25% Insiders
16.76% Mutual Funds
0.31% Other Institutional Investors
13.72% ETFs
59.96% Public Companies and Individual Investors
The ownership structure of Arcutis Biotherapeutics (ARQT) stock is a mix of institutional, retail, and individual investors. Approximately 30.79% of the company’s stock is owned by Institutional Investors, 9.25% is owned by Insiders, and 59.96% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 03, 2026 | xxxxxxxxxxxxx | $92842 | |
Mar 03, 2026 | xxxxxxxxxxxxx | $71842 | |
Mar 03, 2026 | xxxxxxxxxxxxx | $158317 | |
Mar 03, 2026 | xxxxxxxxxxxxx | $169874 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $885923 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $5663758 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $74413402 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $129339978 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,862,862 | Insider | 7.15% | 213,772,231 | |
| 5,729,969 | Institution | 4.62% | 138,206,852 | |
| 4,934,874 | Institution | 3.98% | 119,029,161 | |
| 4,619,727 | Institution | 3.72% | 111,427,815 | |
| 4,453,856 | Institution | 3.59% | 107,427,007 | |
| 4,024,598 | Institution | 3.24% | 97,073,304 | |
| 2,562,445 | Institution | 2.07% | 61,806,173 | |
| 2,145,419 | Institution | 1.73% | 51,747,506 | |
| 1,360,310 | Institution | 1.10% | 32,810,677 | |
| 1,312,446 | Institution | 1.06% | 31,656,198 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,619,727 | Institution | 3.72% | 111,427,815 | |
| 2,145,419 | Institution | 1.73% | 51,747,506 | |
| 1,360,310 | Institution | 1.10% | 32,810,677 | |
| 1,312,446 | Institution | 1.06% | 31,656,198 | |
| 1,136,843 | Institution | 0.92% | 27,420,653 | |
| 1,089,387 | Institution | 0.88% | 26,276,014 | |
| 1,039,625 | Institution | 0.84% | 25,075,755 | |
| 850,058 | Institution | 0.69% | 20,503,399 | |
| 627,132 | Institution | 0.51% | 15,126,424 | |
| 594,733 | Institution | 0.48% | 14,344,960 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,806,132 | Institution | 3.07% | 93,516,663 | |
| 3,462,895 | Institution | 2.79% | 93,394,278 | |
| 2,600,429 | Institution | 2.10% | 62,956,386 | |
| 1,216,932 | Institution | 0.98% | 32,820,656 | |
| 894,581 | Institution | 0.72% | 21,657,806 | |
| 820,708 | Institution | 0.66% | 19,869,341 | |
| 545,268 | Institution | 0.44% | 14,705,878 | |
| 540,115 | Institution | 0.44% | 13,270,626 | |
| 331,464 | Institution | 0.27% | 8,939,584 | |
| 235,781 | Institution | 0.19% | 5,793,139 |
FAQ
Who Owns Arcutis Biotherapeutics (ARQT)?
According to the latest TipRanks data, approximately 0.31% of the company's stock is held by institutional investors, 9.25% is held by insiders, and 59.96% is held by retail investors.
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.31% of Arcutis Biotherapeutics (ARQT) stock is held by institutional investors.
What percentage of Arcutis Biotherapeutics (ARQT) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.96% of Arcutis Biotherapeutics (ARQT) stock is held by retail investors.
Who owns the most shares of Arcutis Biotherapeutics (ARQT)?
Patrick Heron owns the most shares of Arcutis Biotherapeutics (ARQT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.